MAZE
Maze Therapeutics·NASDAQ
--
--(--)
--
--(--)
MAZE fundamentals
Maze Therapeutics (MAZE) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), missed estimates; EPS was -0.77 (YoY --), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.77
--
Report date
Aug 12, 2025
EPS
Actual | -18.32 | -0.77 |
Forecast | 2.05 | -0.836 |
Surprise | -993.66% | +7.89% |
Revenue
Actual | 0 | 0 |
Forecast | 0 | 3.13M |
Surprise | 0.00% | -100.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Maze Therapeutics's revenue and profit?What does Maze Therapeutics do and what are its main business segments?What is Maze Therapeutics's gross profit margin?Did Maze Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Maze Therapeutics next quarter?What were the key takeaways from Maze Therapeutics’s earnings call?What is the revenue and EPS growth rate for Maze Therapeutics year over year?What is Maze Therapeutics's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
